跳至主要内容
临床试验/TCTR20210517001
TCTR20210517001已完成4 期

Can intravenous lidocaine definitely attenuate propofol requirement and improve outcomes among colonoscopic patients under intravenous sedation?: A double-blinded, randomized controlled trial

Phramongkutklao hospital0 个研究点目标入组 68 人开始时间: 2021年5月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
68

研究概览

简要总结

Intravenous lidocaine produced a definitely effective reduced propofol requirement without other sedative agents and improved outcomes including patient satisfaction, duration in returning to BIS more than 85, and sedation score during colonoscopy without adverse effects.

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Patients aged 20 to 80 years
  • 2. American Society of Anesthesiologists physical status I-III

排除标准

  • 1. Severe cardiovascular and pulmonary diseases
  • 2. Liver or renal insufficiency
  • 3. Mental disorders
  • 4. language barrier
  • 5. history of colectomy
  • 6. history of being allergic to lidocaine

研究者

相似试验